Other terms
- Precision GI Medicine
- Precision Medicine
- Precision Oncology
- Presbyopia
- PDUFA
- Proteomics
- Protocol
- Protocol Amendments
- Protocol Deviations
- Prurigo Nodularis
- Pruritus
- Psoriasis
Pre-treatment Genomic-Based Cancer Screening
What is Pre-treatment Genomic-Based Cancer Screening? Pre-treatment genomic-based cancer screening is a type of screening that uses genetic testing to analyze a patient's DNA to identify genetic mutations or alterations that may indicate a higher risk of developing certain types of cancer or may influence the choice of treatment for a patient who has been diagnosed with cancer.
Types of Pre-treatment Genomic-Based Cancer Screening Tests
- DNA sequencing: Analyzes the patient’s DNA to identify specific mutations or alterations that may be present in cancer-related genes.
- RNA sequencing: Analyzes the RNA molecules produced by the patient’s cancer cells to identify specific genetic alterations that may be driving tumor growth.
- Proteomic profiling: Analyzes the proteins produced by the patient’s cancer cells to identify specific biomarkers that may be useful for predicting treatment response.
Source: Genomic vs. Genetic Testing for Cancer. (2022, May 2). Cancer Treatment Centers of America. https://www.cancercenter.com/diagnosing-cancer/genetic-and-genomic-testing
